Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02321566 · ClinicalTrials.gov registry record · Phase 1
Motor Cortex Stimulation for the Treatment of Chronic Facial, Upper Extremity, and Throat Pain.
A Phase 1 study, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- Phase 1
- Development phase
- 1
- Enrollment target
NCT02321566: Clinical Trial Phase 1 study, sponsored by Johns Hopkins University.
NCT02321566 is a Phase 1 study that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02321566, a Phase 1 study, was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 1 participants
- Enrollment target
Study Summary
This study is an open-label study to determine the feasibility of Motor Cortex Stimulation (MCS) in the treatment of patients with chronic pain of the face or upper extremity. MCS will be delivered by use of an electrode and pulse generator, which are FDA approved for spinal cord stimulation but are not approved for MCS. The study has as a single-arm design with the subject at baseline serving as a control for the response to MCS.
Interventions
- DEVICE Epidural Motor Cortex Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2015-02 |
| Est. Completion | 2017-11-21 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02321566
The ClinicalTrials.gov registry entry for NCT02321566 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Epidural Motor Cortex Stimulation is the first listed.
NCT02321566 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02321566 about?
NCT02321566 is a clinical study titled "Motor Cortex Stimulation for the Treatment of Chronic Facial, Upper Extremity, and Throat Pain.". This study is an open-label study to determine the feasibility of Motor Cortex Stimulation (MCS) in the treatment of patients with chronic pain of the face or upper extremity. MCS will be delivered by use of an electrode and pulse generator, which are FDA approved for spinal cord stimulation but are...
What is the current status of trial NCT02321566?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 1 participants. The study started on 2015-02. Estimated completion is 2017-11-21.
What interventions are being tested in trial NCT02321566?
The interventions under investigation include: Epidural Motor Cortex Stimulation (DEVICE).
Who is sponsoring clinical trial NCT02321566?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.